Literature DB >> 2848470

Transient rheumatoid factor positivity in acute human parvovirus B19 infection.

S J Naides1, E H Field.   

Abstract

The relationship between parvovirus B19 infection and classic rheumatoid arthritis remains to be determined. We describe two adult patients with serologically documented acute parvovirus B19 infection who presented with sudden onset of symmetric polyarthritis, skin eruption, and rheumatoid factor positivity. Rheumatoid factor positivity and symptoms resolved within five months. We conclude that a diagnosis of B19 arthropathy should be considered in any patient with recent acute or subacute onset of symmetric polyarthralgia or polyarthritis and rheumatoid factor positivity, which would otherwise suggest a diagnosis of early rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2848470

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  10 in total

Review 1.  Rheumatology.

Authors:  R A Asherson; R Cervera; D P D'Cruz; G R Hughes
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

Review 2.  Vaccine Design Informed by Virus-Induced Immunity.

Authors:  Rhiannon R Penkert; Jane S Hankins; Neal S Young; Julia L Hurwitz
Journal:  Viral Immunol       Date:  2020-05-05       Impact factor: 2.257

Review 3.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

4.  Parvovirus B19-induced constellation of acute renal failure, elevated aminotransferases and congestive heart failure.

Authors:  I W McAuley; F Sepandj; W Schlech
Journal:  Can J Infect Dis       Date:  1997-01

5.  Effect of HLA type and hypocomplementaemia on the expression of parvovirus arthritis: one year follow up of an outbreak.

Authors:  N S Gendi; K Gibson; B P Wordsworth
Journal:  Ann Rheum Dis       Date:  1996-01       Impact factor: 19.103

6.  Auranofin inhibits calcium uptake into opsonized-zymosan-stimulated neutrophils obtained from rats.

Authors:  K Ishitani; A Matsuura; H Honda
Journal:  Inflamm Res       Date:  1995-11       Impact factor: 4.575

7.  Prevalence of antihuman parvovirus B19 IgG antibodies in patients with refractory rheumatoid arthritis and polyarticular juvenile rheumatoid arthritis.

Authors:  A Mimori; Y Misaki; T Hachiya; K Ito; S Kano
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

8.  Serum interleukin-2 receptor for the early diagnosis of rheumatoid arthritis.

Authors:  Y Suenaga; M Yasuda; M Yamamoto; S Nonaka; T Wada; S Shiokawa; M Nobunaga
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

9.  Outcome of patients with arthritis and parvovirus B19 DNA in synovial membranes.

Authors:  Simone Schmid; Walter Bossart; Beat A Michel; Pius Brühlmann
Journal:  Rheumatol Int       Date:  2007-03-31       Impact factor: 3.580

10.  [Virus-associated arthritis].

Authors:  F Günther; M Fleck; B Bach
Journal:  Z Rheumatol       Date:  2017-10       Impact factor: 1.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.